Advanced search
Publication Cover
Diabetes, Metabolic Syndrome and Obesity Volume 13, 2020 - Issue
Submit an article Journal homepage
139
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Determinants of Statin Initiation Among Adult Diabetic Patients in Bonga, Ethiopia

Bezie Kebede zelalemSchool of Pharmacy, College of Health Science, Mizan-Tepi University, Mizan-Teferi, EthiopiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2257-8228View further author information
ORCID Icon &
Desalegn FeyisaSchool of Pharmacy, College of Health Science, Mizan-Tepi University, Mizan-Teferi, EthiopiaORCID Iconhttps://orcid.org/0000-0002-5781-0368View further author information
ORCID Icon
Pages 4839-4847 | Published online: 08 Dec 2020

References

  • Marcellusi A, Viti R, Sciattella P, et al. Economic aspects in the management of diabetes in Italy. BMJ Open Diabeties Res Care. 2016;1–11.
  • American Heart Organization. Statistical fact sheet-populations international cardiovascular disease statistics. Am Hear Organ. 2004.
  • Pagidipati NJ, Navar AM, Pieper KS, et al. with type 2 diabetes: international insights from the TECOS trial. HHS Public Access. 2018;136(13):1193–1203.
  • Nowbar AN, Gitto M, Howard JP, Francis DP, Al-Lamee R. Mortality from ischemic heart disease. BMJ Open Diabetes Res Care. 2019;12(6):6. doi:10.1161/CIRCOUTCOMES.118.005375
  • de SE SA, De Siqueira-filho AG, Land MGP. Análise do impacto econômico das doenças cardiovasculares nos últimos cinco anos no brasil. Arq Bras Cardiol. 2017;109(1):39–46.
  • Shumer E, Norman P, Spack NJN. HHS Public Access. 2017;176(12):139–148.
  • Sources D, Selection S, Extraction D, Outcomes M. Statins for prevention of cardiovascular disease in adults. JAMA. 2016;(19):2008–2024.
  • Kim G, Jang SY, Nam CM, Kang ES. Statin use and the risk of hepatocellular carcinoma in patients at high risk: a nationwide nested case-control study. J Hepatol. 2018;68(3):476–484. doi:10.1016/j.jhep.2017.10.018.
  • Li M, Wang X, Li X, et al. Statins for the primary prevention of coronary heart disease. Biomed Res Int. 2019;2019.
  • Demoz GT, Wahdey S, Kasahun GG, et al. Prescribing pattern of statins for primary prevention of cardiovascular diseases in patients with type 2 diabetes: insights from Ethiopia. BMC Res Notes. 2019;12:1–7. doi:10.1186/s13104-019-4423-9;.
  • Arnett DK, Blumenthal RS, Albert MA, et al. ACC/AHA guideline on the primary prevention of cardiovascular disease 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease. Am Coll Cardiol. 2019;2019.
  • Yashashwi Pokharel JM, Akeroyd DJ, Ramsey RS, et al. Statin use and its facility-level variation in patients with diabetes: insight from the veterans affairs national database. Clin Cardiol. 2016;39(4):185–191. doi:10.1002/clc.22503
  • Arca M, Ansell D, Averna M, et al. Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: insights from Italian general practice. Atherosclerosis. 2018;271:120–127. doi:10.1016/j.atherosclerosis.2018.02.024
  • Brown F, Singer A, Katz A, Brown F, Singer A. Statin-prescribing trends for primary and secondary prevention of cardiovascular disease recherche tendances actuelles dans la prescription des statines en prévention primaire et secondaire des maladies cardiovasculaires. Can Fam Physician. 2017;63:495–503.
  • Zhang H, Plutzky J, Shubina M, Turchin A. Risk factors for lack of statin therapy in patients with diabetes and coronary artery disease. J Clin Lipidol. 2016;10(6):1406–1413. doi:10.1016/j.jacl.2016.09.010.
  • Stone NJ, Robinson JG, Lichtenstein AH, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiolo. Circulationation. 2014;129(25 suppl 2):S1–45. doi:10.1161/01.cir.0000437738.63853.7a
  • Gupta R, Lodha S, Sharma KK, et al. Evaluation of statin prescriptions in type 2 diabetes: India heart watch-2. BMJ Open Diabetes Res Care. 2016;4(1):1–7. doi:10.1136/bmjdrc-2016-000275
  • Khalil S, Khayyat S, Al-khadra Y, et al. Expert review of cardiovascular therapy should all diabetic patients take statin therapy regardless of serum cholesterol level ? Should all diabetic patients take statin therapy regardless of serum cholesterol. Expert Rev Cardiovasc Ther. 2019;17(4):237–239. doi:10.1080/14779072.2019.1590198
  • Subedi BH, Michael G, Minder CM, et al. The role of statins in diabetes treatment. Diabetes Spectr. 2013;26(3):3. doi:10.2337/diaspect.26.3.156
  • Dixon BDL, Pharm D, Cardiology B, et al. Primary prevention of cardiovascular disease. Prim Prev Cardiovasc Dis. 2018.
  • Mph AP, Eli J, Mha A, Fund N, Ma AC, Fesc MM. Statin therapy: diabetes mellitus risk and cardiovascular benefit in primary prevention. IMAJ. 2018;20:480–485.
  • Khan NNS, Kelly-blake K, Luo Z, Olomu A. Sex differences in statin prescribing in diabetic and heart disease patients in FQHCs: a comparison of the ATPIII and 2013 ACC/AHA cholesterol guidelines. Heal Serv Res Manag Epidemiol. 2019;6:1–8.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.